PMP22-related disease

A novel splice site acceptor variant and intrafamilial phenotype variability

Toshitaka Kawarai, Hiroki Yamazaki, Ryosuke Miyamoto, Naoko Takamatsu, Atsuko Mori, Yusuke Osaki, Antonio Orlacchio, Hiroyuki Nodera, Akihiro Hashiguchi, Yujiro Higuchi, Akiko Yoshimura, Hiroshi Takashima, Ryuji Kaji

Research output: Contribution to journalArticle

Abstract

PMP22 is the most frequent mutated gene in Charcot-Marie-Tooth disease (CMT)type 1A. Another phenotype, hereditary neuropathy with pressure palsies (HNPP), could be caused by PMP22 mutations. PMP22 encodes a peripheral myelin protein with molecular weight 22-kDa. Various pathomechanisms have been postulated in PMP22-related disease, including dysfunction due to missense mutations, and alteration of a gene dose due to duplication/deletion mutations. We identified a novel PMP22 splice site acceptor variant, c.179–1G>A, in a patient with adult-onset chronic generalized polyneuropathy and two asymptomatic family members. Pathophysiological features of the members mainly overlapped with those reported in HNPP, but broad intrafamilial clinical variations were observed. PMP22 transcripts lacking of exon 4 were produced by the variant, presumably leading to in-frame deletion of 47 amino acids. The variant was also shown to exert effect on dosage of PMP22 mRNA. The complex molecular pathology would lead to the unique clinical and pathophysiological conditions.

Original languageEnglish
JournalNeuromuscular Disorders
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

RNA Splice Sites
Paralysis
Myelin Proteins
Phenotype
Charcot-Marie-Tooth Disease
Pressure
Molecular Pathology
Polyneuropathies
Sequence Deletion
Missense Mutation
Genes
Exons
Molecular Weight
Amino Acids
Messenger RNA
Mutation

Keywords

  • Gene dose effect
  • Overlapped pathophysiology
  • PMP22 protein with in-frame deletion
  • PMP22-related disease
  • Splice site acceptor variant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Clinical Neurology
  • Genetics(clinical)

Cite this

PMP22-related disease : A novel splice site acceptor variant and intrafamilial phenotype variability. / Kawarai, Toshitaka; Yamazaki, Hiroki; Miyamoto, Ryosuke; Takamatsu, Naoko; Mori, Atsuko; Osaki, Yusuke; Orlacchio, Antonio; Nodera, Hiroyuki; Hashiguchi, Akihiro; Higuchi, Yujiro; Yoshimura, Akiko; Takashima, Hiroshi; Kaji, Ryuji.

In: Neuromuscular Disorders, 01.01.2019.

Research output: Contribution to journalArticle

Kawarai, T, Yamazaki, H, Miyamoto, R, Takamatsu, N, Mori, A, Osaki, Y, Orlacchio, A, Nodera, H, Hashiguchi, A, Higuchi, Y, Yoshimura, A, Takashima, H & Kaji, R 2019, 'PMP22-related disease: A novel splice site acceptor variant and intrafamilial phenotype variability', Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2019.03.010
Kawarai, Toshitaka ; Yamazaki, Hiroki ; Miyamoto, Ryosuke ; Takamatsu, Naoko ; Mori, Atsuko ; Osaki, Yusuke ; Orlacchio, Antonio ; Nodera, Hiroyuki ; Hashiguchi, Akihiro ; Higuchi, Yujiro ; Yoshimura, Akiko ; Takashima, Hiroshi ; Kaji, Ryuji. / PMP22-related disease : A novel splice site acceptor variant and intrafamilial phenotype variability. In: Neuromuscular Disorders. 2019.
@article{a7d8a492e53a45d4be934eeab4b45106,
title = "PMP22-related disease: A novel splice site acceptor variant and intrafamilial phenotype variability",
abstract = "PMP22 is the most frequent mutated gene in Charcot-Marie-Tooth disease (CMT)type 1A. Another phenotype, hereditary neuropathy with pressure palsies (HNPP), could be caused by PMP22 mutations. PMP22 encodes a peripheral myelin protein with molecular weight 22-kDa. Various pathomechanisms have been postulated in PMP22-related disease, including dysfunction due to missense mutations, and alteration of a gene dose due to duplication/deletion mutations. We identified a novel PMP22 splice site acceptor variant, c.179–1G>A, in a patient with adult-onset chronic generalized polyneuropathy and two asymptomatic family members. Pathophysiological features of the members mainly overlapped with those reported in HNPP, but broad intrafamilial clinical variations were observed. PMP22 transcripts lacking of exon 4 were produced by the variant, presumably leading to in-frame deletion of 47 amino acids. The variant was also shown to exert effect on dosage of PMP22 mRNA. The complex molecular pathology would lead to the unique clinical and pathophysiological conditions.",
keywords = "Gene dose effect, Overlapped pathophysiology, PMP22 protein with in-frame deletion, PMP22-related disease, Splice site acceptor variant",
author = "Toshitaka Kawarai and Hiroki Yamazaki and Ryosuke Miyamoto and Naoko Takamatsu and Atsuko Mori and Yusuke Osaki and Antonio Orlacchio and Hiroyuki Nodera and Akihiro Hashiguchi and Yujiro Higuchi and Akiko Yoshimura and Hiroshi Takashima and Ryuji Kaji",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.nmd.2019.03.010",
language = "English",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - PMP22-related disease

T2 - A novel splice site acceptor variant and intrafamilial phenotype variability

AU - Kawarai, Toshitaka

AU - Yamazaki, Hiroki

AU - Miyamoto, Ryosuke

AU - Takamatsu, Naoko

AU - Mori, Atsuko

AU - Osaki, Yusuke

AU - Orlacchio, Antonio

AU - Nodera, Hiroyuki

AU - Hashiguchi, Akihiro

AU - Higuchi, Yujiro

AU - Yoshimura, Akiko

AU - Takashima, Hiroshi

AU - Kaji, Ryuji

PY - 2019/1/1

Y1 - 2019/1/1

N2 - PMP22 is the most frequent mutated gene in Charcot-Marie-Tooth disease (CMT)type 1A. Another phenotype, hereditary neuropathy with pressure palsies (HNPP), could be caused by PMP22 mutations. PMP22 encodes a peripheral myelin protein with molecular weight 22-kDa. Various pathomechanisms have been postulated in PMP22-related disease, including dysfunction due to missense mutations, and alteration of a gene dose due to duplication/deletion mutations. We identified a novel PMP22 splice site acceptor variant, c.179–1G>A, in a patient with adult-onset chronic generalized polyneuropathy and two asymptomatic family members. Pathophysiological features of the members mainly overlapped with those reported in HNPP, but broad intrafamilial clinical variations were observed. PMP22 transcripts lacking of exon 4 were produced by the variant, presumably leading to in-frame deletion of 47 amino acids. The variant was also shown to exert effect on dosage of PMP22 mRNA. The complex molecular pathology would lead to the unique clinical and pathophysiological conditions.

AB - PMP22 is the most frequent mutated gene in Charcot-Marie-Tooth disease (CMT)type 1A. Another phenotype, hereditary neuropathy with pressure palsies (HNPP), could be caused by PMP22 mutations. PMP22 encodes a peripheral myelin protein with molecular weight 22-kDa. Various pathomechanisms have been postulated in PMP22-related disease, including dysfunction due to missense mutations, and alteration of a gene dose due to duplication/deletion mutations. We identified a novel PMP22 splice site acceptor variant, c.179–1G>A, in a patient with adult-onset chronic generalized polyneuropathy and two asymptomatic family members. Pathophysiological features of the members mainly overlapped with those reported in HNPP, but broad intrafamilial clinical variations were observed. PMP22 transcripts lacking of exon 4 were produced by the variant, presumably leading to in-frame deletion of 47 amino acids. The variant was also shown to exert effect on dosage of PMP22 mRNA. The complex molecular pathology would lead to the unique clinical and pathophysiological conditions.

KW - Gene dose effect

KW - Overlapped pathophysiology

KW - PMP22 protein with in-frame deletion

KW - PMP22-related disease

KW - Splice site acceptor variant

UR - http://www.scopus.com/inward/record.url?scp=85065707113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065707113&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2019.03.010

DO - 10.1016/j.nmd.2019.03.010

M3 - Article

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

ER -